Lv2
130 积分 2023-12-07 加入
Multisystem immune-related adverse events during combined ipilimumab-nivolumab with subsequent disease progression: a case report
2个月前
已完结
Multisystem immune-related adverse reactions with immune checkpoint inhibitors
2个月前
已关闭
Anti-PD-1 and Regorafenib Induce Severe Multisystem Adverse Events in Microsatellite Stability Metastatic Colorectal Cancer: A Case Report
2个月前
已完结
Primary Biliary Cirrhosis and Granulomatous Hepatitis After Immune Checkpoint Blockade in Patients With Metastatic Melanoma: Report of 2 Cases and Literature Discussion
2个月前
已完结
Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer
3个月前
已完结
Multi-organ immune-related adverse events from immune checkpoint inhibitors and their downstream implications: a retrospective multicohort study
4个月前
已完结
Network pharmacology, molecular docking and experimental study of CEP in nasopharyngeal carcinoma
4个月前
已完结
Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines
5个月前
已完结
C-X-C-chemokine-receptor-type-4 as a potential target for diagnosis and treatment of acute radiation-induced esophagitis
6个月前
已完结
Factors associated with acute esophagitis during radiation therapy for lung cancer
6个月前
已关闭
皖公网安备34019202002308
